Shedding of PECAM-1 during HIV infection: A potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS

Journal of Leukocyte Biology

Volumn 79, Issue 3, 2006, Pages 444-452

  Eugenin, E A ^a   Gamss, R ^a   Buckner, C ^a   Buono, D ^a   Klein, R S ^a   Schoenbaum, E E ^a   Calderon, T M ^a   Berman, J W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CCL2; Encephalitis; Leukocytes; Transmigration

Indexed keywords

CD31 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE FRAGMENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD BRAIN BARRIER; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; ADOLESCENT; ADULT; BIOLOGICAL MODEL; BRAIN; CHILD; EXTRACELLULAR SPACE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFANT; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ADOLESCENT; ADULT; AIDS DEMENTIA COMPLEX; ANTIGENS, CD31; BLOOD-BRAIN BARRIER; BRAIN; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; EXTRACELLULAR SPACE; HIV-1; HUMANS; INFANT; MIDDLE AGED; MODELS, BIOLOGICAL; MONOCYTES; PEPTIDE FRAGMENTS;

EID: 33645294809     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0405215     Document Type: Article

References (47)

1. Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A., Mills, R. G., Wachsman, W., Wiley, C. A. (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42, 1736-1739.
2. Bell, J. E. (1998) The neuropathology of adult HIV infection. Rev. Neurol. (Paris) 154, 816-829.
3. Strelow, L. I., Janigro, D., Nelson, J. A. (2001) The blood-brain barrier and AIDS. Adv. Virus Res. 56, 355-388.
4. Picker, L. J., Watkins, D. I. (2005) HIV pathogenesis: the first cut is the deepest. Nat. Immunol. 6, 430-432.
5. Carlos, T. M., Harlan, J. M. (1994) Leukocyte-endothelial adhesion molecules. Blood 84, 2068-2101.
6. Muller, W. A., Ratti, C. M., McDonnell, S. L., Cohn, Z. A. (1989) A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J. Exp. Med. 170, 399-414.
7. Newman, P. J., Berndt, M. C., Gorski, J., White II, G. C., Lyman, S., Paddock, C., Muller, W. A. (1990) PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247, 1219-1222.
8. Albelda, S. M., Oliver, P. D., Romer, L. H., Buck, C. A. (1990) EndoCAM: a novel endothelial cell-cell adhesion molecule. J. Cell Biol. 110, 1227-1237.
9. Stockinger, H., Gadd, S. J., Eher, R., Majdic, O., Schreiber, W., Kasinrerk, W., Strass, B., Schnabl, E., Knapp, W. (1990) Molecular characterization and functional analysis of the leukocyte surface protein CD31. J. Immunol. 145, 3889-3897.
10. Simmons, D. L., Walker, C., Power, C., Pigott, R. (1990) Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. Exp. Med. 171, 2147-2152.
11. Muller, W. A., Weigl, S. A., Deng, X., Phillips, D. M. (1993) PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178, 449-460.
12. Berman, M. E., Xie, Y., Muller, W. A. (1996) Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and β 2 integrin activation. J. Immunol. 156, 1515-1524.
13. Aurrand-Lions, M., Johnson-Leger, C., Imhof, B. A. (2002) The last molecular fortress in leukocyte trans-endothelial migration. Nat. Immunol. 3, 116-118.
14. Muller, W. A. (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24, 327-334.
15. Qing, Z., Sandor, M., Radvany, Z., Sewell, D., Falus, A., Potthoff, D., Muller, W. A., Fabry, Z. (2001) Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J. Neuropathol. Exp. Neurol. 60, 798-807.
16. Graesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B., Madri, J. A. (2002) Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109, 383-392.
17. Vaporciyan, A. A., DeLisser, H. M., Yan, H. C., Mendiguren, I. I., Thom, S. R., Jones, M. L., Ward, P. A., Albelda, S. M. (1993) Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262, 1580-1582.
18. Bogen, S., Pak, J., Garifallou, M., Deng, X., Muller, W. A. (1994) Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179, 1059-1064.
19. Liao, F., Huynh, H. K., Eiroa, A., Greene, T., Polizzi, E., Muller, W. A. (1995) Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182, 1337-1343.
20. Wakelin, M. W., Sanz, M. J., Dewar, A., Albelda, S. M., Larkin, S. W., Boughton-Smith, N., Williams, T. J., Nourshargh, S. (1996) An antiplatelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J. Exp. Med. 184, 229-239.
21. Sasseville, V. G., Newman, W. A., Lackner, A. A., Smith, M. O., Lausen, N. C., Beall, D., Ringler, D. J. (1992) Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141, 1021-1030.
22. Seilhean, D., Dzia-Lepfoundzou, A., Sazdovitch, V., Cannella, B., Raine, C. S., Katlama, C., Bricaire, F., Duyckaerts, C., Hauw, J. J. (1997) Astrocytic adhesion molecules are increased in HIV-1-associated cognitive/motor complex. Neuropathol. Appl. Neurobiol. 23, 83-92.
23. Navia, B. A., Cho, E. S., Petito, C. K., Price, R. W. (1986) The AIDS dementia complex: II. neuropathology. Ann. Neurol. 19, 525-535.
24. Wiley, C. A., Masliah, E., Morey, M., Lemere, C., DeTeresa, R., Grafe, M., Hansen, L., Terry, R. (1991) Neocortical damage during HIV infection. Ann. Neurol. 29, 651-657.
25. Wiley, C. A., Achim, C. (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36, 673-676.
26. Dallasta, L. M., Pisarov, L. A., Esplen, J. E., Werley, J. V., Moses, A. V., Nelson, J. A., Achim, C. L. (1999) Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1915-1927.
27. Boven, L. A., Middel, J., Verhoef, J., De Groot, C. J., Nottet, H. S. (2000) Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol. Appl. Neurobiol. 26, 356-360.
28. Eugenin, E. A., Berman, J. W. (2003) Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 29, 351-361.
29. Webber, M. P., Schoenbaum, E. E., Gourevitch, M. N., Buono, D., Klein, R. S. (1999) A prospective study of HIV disease progression in female and male drug users. AIDS 13, 257-262.
30. Kohli, R., Lo, Y., Howard, A. A., Buono, D., Floris-Moore, M., Klein, R. S., Schoenbaum, E. E. (2005) Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 41, 864-872.
31. Miller, S. A., Santoro, N., Lo, Y., Howard, A. A., Arnsten, J. H., Floris-Moore, M., Moskaleva, G., Schoenbaum, E. E. (2005) Menopause symptoms in HIV-infected and drug-using women. Menopause 12, 348-356.
32. Sun, Q. H., DeLisser, H. M., Zukowski, M. M., Paddock, C., Albelda, S. M., Newman, P. J. (1996) Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J. Biol. Chem. 271, 11090-11098.
33. Sun, J., Williams, J., Yan, H. C., Amin, K. M., Albelda, S. M., DeLisser, H. M. (1996) Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J. Biol. Chem. 271, 18561-18570.
34. Muller, W. A., Randolph, G. J. (1999) Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leukoc. Biol. 66, 698-704.
35. Engelhardt, B., Wolburg, H. (2004) Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur. J. Immunol. 34, 2955-2963.
36. Goldberger, A., Middleton, K. A., Oliver, J. A., Paddock, C., Yan, H. C., DeLisser, H. M., Albelda, S. M., Newman, P. J. (1994) Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J. Biol. Chem. 269, 17183-17191.
37. Ilan, N., Mohsenin, A., Cheung, L., Madri, J. A. (2001) PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J. 15, 362-372.
38. Leeuwenberg, J. F., Smeets, E. F., Neefjes, J. J., Shaffer, M. A., Cinek, T., Jeunhomme, T. M., Ahern, T. J., Buurman, W. A. (1992) E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77, 543-549.
39. Liao, F., Ali, J., Greene, T., Muller, W. A. (1997) Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J. Exp. Med. 185, 1349-1357.
40. Blann, A. D., Lip, G. Y., Fijnheer, R. (1999) Significance of soluble P-selectin, von Willebrand factor, and other adhesion molecules in hypercholesterolemia and peripheral artery disease. Circulation 99, 2478-2479.
41. Maas, M., Stapleton, M., Bergom, C., Mattson, D. L., Newman, D. K., Newman, P. J. (2005) Endothelial cell PECAM-1 confers protection against endotoxic shock. Am. J. Physiol. Heart Circ. Physiol. 288, H159-H164.
42. Duncan, G. S., Andrew, D. P., Takimoto, H., Kaufman, S. A., Yoshida, H., Spellberg, J., Luis de la Pompa, J., Elia, A., Wakeham, A., Karan-Tamir, B., Muller, W. A., Senaldi, G., Zukowski, M. M., Mak, T. W. (1999) Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162, 3022-3030.
43. D'Aversa, T. G., Eugenin, E. A., Berman, J. W. (2005) NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins tat and gp120 as well as CD40 to microglial activation. J. Neurosci. Res. 81, 436-446.
44. Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D., Imhof, B. A. (1995) CD31/PECAM-1 is a ligand for α v β 3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130, 451-460.
45. Buckley, C. D., Doyonnas, R., Newton, J. P., Blystone, S. D., Brown, E. J., Watt, S. M., Simmons, D. L. (1996) Identification of α v β 3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109, 437-445.
46. DeLisser, H. M., Yan, H. C., Newman, P. J., Muller, W. A., Buck, C. A., Albelda, S. M. (1993) Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J. Biol. Chem. 268, 16037-16046.
47. Ilan, N., Madri, J. A. (2003) PECAM-1: old friend, new partners. Curr. Opin. Cell Biol. 15, 515-524.